Listen to this episode from The Daily on Spotify.

From the start of the pandemic, the US said it was committed to ordering and stockpiling enough potential vaccine doses to end the outbreak in the United States as quickly as possible.

But new reporting from The Times has revealed that Pfizer, the maker of the first vaccine to show effectiveness against the coronavirus, tried unsuccessfully to get the government to lock in 100 million extra doses.

Today, we investigate how the Trump administration missed that opportunity and what the repercussions might be.Guest: Sharon LaFraniere, an investigative reporter for The New York Times...

Listen to this episode from The Daily on Spotify.

From the start of the pandemic, the US said it was committed to ordering and stockpiling enough potential vaccine doses to end the outbreak in the United States as quickly as possible.

But new reporting from The Times has revealed that Pfizer, the maker of the first vaccine to show effectiveness against the coronavirus, tried unsuccessfully to get the government to lock in 100 million extra doses.

Today, we investigate how the Trump administration missed that opportunity and what the repercussions might be.Guest: Sharon LaFraniere, an investigative reporter for The New York Times...